2019
Safety and costs of blood transfusion practices in dengue cases in Brazil
Machado A, Negrão F, Croda J, de Medeiros E, dos Santos Pires M. Safety and costs of blood transfusion practices in dengue cases in Brazil. PLOS ONE 2019, 14: e0219287. PMID: 31283788, PMCID: PMC6613682, DOI: 10.1371/journal.pone.0219287.Peer-Reviewed Original ResearchConceptsHospital stayHospitalization timeHospitalisation timeWHO criteriaBlood transfusion componentsCost of hospitalisationWorld Health Organization recommendationsProspective observational studyBlood transfusion practicesPublic health problemTransfused groupBlood transfusionHospitalisation costsTransfusion practiceMedical recordsObservational studyTransfusion componentsWHO recommendationsPatientsTransfusionHealth problemsBlood componentsDengue casesStayHospitalisation
2018
National trends in Fontan operation and in-hospital outcomes in the USA
Akintoye E, Miranda W, Veldtman G, Connolly H, Egbe A. National trends in Fontan operation and in-hospital outcomes in the USA. Heart 2018, 105: 708-714. PMID: 30377261, DOI: 10.1136/heartjnl-2018-313680.Peer-Reviewed Original ResearchConceptsFontan operationHospital mortalityPostoperative complicationsClinical Modification procedure codesHypoplastic left heart syndromePostoperative cardiac complicationsCongenital heart disease diagnosisNationwide Inpatient SampleAcute care facilitiesLength of stayNumber of patientsDiseases-Ninth RevisionVolume of proceduresSignificant declineNumber of proceduresCardiac complicationsRespiratory complicationsHospital dischargeHospital outcomesPatient demographicsMedian ageHeart syndromeHospitalisation costsPatient populationSignificant changes
2014
Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011
Lampropulos JF, Kim N, Wang Y, Desai MM, Barreto-Filho JA, Dodson JA, Dries DL, Mangi AA, Krumholz HM. Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011. Open Heart 2014, 1: e000109. PMID: 25332817, PMCID: PMC4189322, DOI: 10.1136/openhrt-2014-000109.Peer-Reviewed Original ResearchDischarge dispositionLVAD implantationMortality rateRehospitalisation ratesIndex hospitalisationImplantation rateLeft ventricular assist device useVentricular assist device useMedicaid Services paymentsProportion of patientsLong-term outcomesPost-procedure lengthUse of LVADsDevice implantation ratesHospital daysHospitalisation costsHeartMate IILVAD useMedicare feeMedicare populationMedicare beneficiariesService beneficiariesHospitalisationDevice useStay
2011
Two-year Vascular Hospitalisation Rates and Associated Costs in Patients at Risk of Atherothrombosis in France and Germany: Highest Burden for Peripheral Arterial Disease
Smolderen KG, Wang K, de Pouvourville G, Brüggenjürgen B, Röther J, Zeymer U, Parhofer KG, Steg PG, Bhatt DL, Magnuson EA, Investigators R. Two-year Vascular Hospitalisation Rates and Associated Costs in Patients at Risk of Atherothrombosis in France and Germany: Highest Burden for Peripheral Arterial Disease. European Journal Of Vascular And Endovascular Surgery 2011, 43: 198-207. PMID: 22001145, DOI: 10.1016/j.ejvs.2011.09.016.Peer-Reviewed Original ResearchConceptsPeripheral arterial diseaseCoronary artery diseaseHospitalisation ratesCerebrovascular diseaseArterial diseaseMultiple risk factorsRisk of atherothrombosisMRF groupPAD subgroupsREACH RegistryCardiovascular eventsPeripheral revascularizationArtery diseaseHospitalisation costsAtherothrombotic diseasePeripheral proceduresRisk factorsRisk groupsHigh burdenEconomic burdenPatientsDiseaseAtherothrombosisEvaluated groupAssociated costs
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply